USANA Health Sciences, Inc. announced preliminary third quarter results, including 2021 net sales expected to reach between $265 to $275 million, a decrease from the prior year period’s $299 million.
USANA’s first annual sustainability report, a document that provides an overview of the company’s priorities and management of its corporate sustainability efforts, including environmental, social and governance (ESG), shows the company’s progress within the 2020 fiscal year.
USANA CEO and chairman Kevin Guest announced the company’s next big humanitarian goal: raising enough money to fund 30,000 garden towers around the world by USANA’s 30th anniversary convention next year.
Individual brands always acknowledge the importance of reputation. When induvial brands use the same channel of distribution, they collectively form a brand.
USANA Health Sciences, Inc. announced a record-breaking second quarter, reporting a 30.1% increase in net sales year-over-year, totaling $336.8 million. The company’s active customers also increased 8.8%, to a record-breaking total of 652,000. Diluted EPS increased 47.1% year-over-year to $1.87.
A good reputation is the intangible but key ingredient for any company seeking to drive growth. And while it can’t be purchased, companies who fail to heavily invest in building it won’t survive.
From the June 2021 issue of Direct Selling News magazine. Each year, the Direct Selling News team works with companies around the world on the Global 100 Celebration, and it has become our signature research endeavor. The goal from the outset of the project 12 years ago was to foster a greater level of transparency within the direct selling community, in […]
Kevin Guest, USANA CEO: Leading by Example This year’s Bravo Leadership Award was awarded to Kevin Guest, Chief Executive Officer of USANA Health Sciences, for his visionary leadership and strategic direction throughout his nearly thirty years with the company. While he’s quick to shift the attention back to the company and its successes over the years, we managed to glean some thoughts on leadership from Kevin, […]
USANA Health Sciences, Inc., along with its Chinese subsidiary, BabyCare, Ltd., announced a research collaboration agreement with the Beijing University of Chinese Medicine (BUCM). Through this partnership, USANA and BUCM will share research to unite modern nutritional science with Traditional Chinese Medicine and potentially improve the health and wellness of people around the world. Together, […]
With the benefit of time and distance, 2020 sales numbers and some hindsight, these industry leaders take a short, retrospective look inside their companies during a year like no other. In so doing, they help the direct selling industry re-think crises while telling the stories of how their teams met disruptive challenges and leveraged 2020’s new business reality to create a renewal that re-energized their field organizations and helped solidify their growth trajectories for 2021 and beyond.
As USANA moved into 2020, the year started strong. A surprise, 100-day nutritional supplement review by the Chinese government had slowed their business in 2019. Still, they realigned their operational spend, invested in IT infrastructure, devised a new road map focusing on new categories, and started building momentum in their non-China markets.
USANA Health Sciences, Inc. released its Q1 2021 financial reports. The company’s first quarter net sales increased 15.5% year-over-year, totaling $308 million, and a diluted EPS increase of 17.9% year-over-year to $1.45. There was also a repurchase of 721,000 shares for $69.5 million during Q1. Active customers during the quarter increased 7.7% over the same […]